MedPath

Steroids (Hydrocortisone), Thiamine and Ascorbic Acid Supplementation in Septic Shock

Phase 3
Recruiting
Conditions
Sepsis.
Other sepsis
Registration Number
IRCT20160901029640N2
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Septic shock patients -as defined by SEPSIS-3- hospitalized in the ICU in the first 24 hours

Exclusion Criteria

Vasopressor use prior to randomization for more than 24 hours
Patients with limitation of care (Decision has been made to reduce the level of care)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
28-day mortality rate. Timepoint: Up to 28th day of hospitalization in intensive care unit. Method of measurement: Checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath